The store will not work correctly when cookies are disabled.
4-Methylamino-N7-(5'-deoxy-beta-D-ribofuranosyl)-pyrrol[2,3-d]pyrimidine
ID: ALA5178932
PubChem CID: 168271767
Max Phase: Preclinical
Molecular Formula: C12H16N4O3
Molecular Weight: 264.29
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNc1ncnc2c1ccn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C12H16N4O3/c1-6-8(17)9(18)12(19-6)16-4-3-7-10(13-2)14-5-15-11(7)16/h3-6,8-9,12,17-18H,1-2H3,(H,13,14,15)/t6-,8-,9-,12-/m1/s1
Standard InChI Key: UEGLYEJMOGRKAU-WOUKDFQISA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-1.7688 0.4048 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2536 -0.2626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0788 -0.2626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7688 -0.9301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0237 -1.7147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9842 -0.6751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3167 -1.1600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9842 0.1498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3167 0.6348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4679 0.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8035 -0.3738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6240 -0.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1089 0.2074 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7733 0.9610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2582 1.6285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0788 1.5423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9528 1.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4679 1.7147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3167 1.4598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 1
2 4 1 0
4 5 1 6
6 4 1 0
6 7 1 6
8 6 1 0
1 8 1 0
8 9 1 1
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
17 14 1 0
10 17 2 0
18 17 1 0
19 18 2 0
19 9 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 264.29 | Molecular Weight (Monoisotopic): 264.1222 | AlogP: 0.11 | #Rotatable Bonds: 2 |
Polar Surface Area: 92.43 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.48 | CX Basic pKa: 6.36 | CX LogP: 0.07 | CX LogD: 0.03 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.71 | Np Likeness Score: 0.71 |
References
1. Lin C, Jaén Batista DDG, Mazzeti AL, Donola Girão R, de Oliveira GM, Karalic I, Hulpia F, Soeiro MNC, Maes L, Caljon G, Van Calenbergh S.. (2022) N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation., 231 [PMID:35144125] [10.1016/j.ejmech.2022.114165] |